Skip to main content
Clinical Trials/NCT03351218
NCT03351218
Completed
Not Applicable

Neuronal Correlates of Agency in Dystonia

Institut National de la Santé Et de la Recherche Médicale, France1 site in 1 country76 target enrollmentOctober 23, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dystonia, Primary
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
76
Locations
1
Primary Endpoint
agency tasks behavioral outcome measures
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

In this study, using computerized cognitive assessments combined with multi-modal neuroimaging approach investigators aim to address three specific questions on patients with cervical and myoclonus dystonia:

(i) investigate various aspects of the sense of agency and relationship to the severity of dystonia symptoms, (ii) characterize the possible link between abnormalities of movement perception and alteration of sense of agency in dystonia, (iii) (identify the neuronal underpinnings of the defective sense of agency in dystonia.

Detailed Description

This is a single-centre, two-group ( dystonia and control), case-control study using behavioural and novel multimodal neuroimaging techniques to address the study aims. The battery of the tasks will include explicit-agency tasks, a visual discrimination task on objects movement perception. The magnetic resonance acquisition protocol will include MP2RAGE structural (10 min duration), multi echo (3 echo times) multiband (MB factor 4) resting state functional neuroimaging (15 minutes duration) and multi shell diffusion imaging sequence (15 minutes duration)

Registry
clinicaltrials.gov
Start Date
October 23, 2017
End Date
December 20, 2022
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of isolated adult-onset cervical dystonia (CD) or myoclonus dystonia (MD);
  • duration of disease of more than one year
  • no botulinum toxin injection for at least three months before the study
  • normal or corrected-to-normal vision.
  • Exclusion Criteria
  • any neurological history except for dystonia,
  • history of dopamine antagonist treatment,
  • secondary dystonia,
  • dystonia in the upper limbs,
  • inability to maintain gaze straight.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

agency tasks behavioral outcome measures

Time Frame: throughout study completion, an average 2 years

response accuracy in tasks trials

Secondary Outcomes

  • MRI measures(throughout study completion, an average 2 years)

Study Sites (1)

Loading locations...

Similar Trials